Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Ask The Pharmacist: CGRP Therapies for Migraine Management in Workers' Compensation
How can CGRP therapies improve outcomes in workers’ compensation migraine claims?Migraines affect around one
Workers' Comp
Article
Migraine Medication Trends in Work Comp
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dig into part one of our
Workers' Comp
Podcast
Calculating the Value of Evidence-Based PT
Workers' Comp
Conference
Workers’ Compensation Institute (WCI) 2025 Conference
Enlyte is proud to return as an Elite Sponsor at the 2025 Workers' Compensation Institute (WCI) Conference in Orlando, Florida—th
Workers' Comp
Article
Reclaim Control Over Specialty Costs
The Growing Surge in Specialty Service CostsAs specialty services become a major driver of rising expenses, effective management of medica
Workers' Comp
Article
Revolutionizing Specialty Services Management
The Hidden Costs of Administrative ComplexityManaging specialty services claims is a balancing act.